Showing results (31-40 of 291) with videos related to

Sort By:
Pageof 30
Movement Disorders : Official Journal of the Movement Disorder Society|November 15, 2012
Dopamine agonists and delusional jealousy in Parkinson's disease: a cross-sectional prevalence studyMichele Poletti, Giulio Perugi, Chiara Logi, et al.
Journal of the International Neuropsychological Society : JINS|October 22, 2011
Event-based prospective memory in newly diagnosed, drug-naive Parkinson's disease patientsCristina Pagni, Daniela Frosini, Roberto Ceravolo, et al.
Clinical Pharmacokinetics|July 8, 2003
Clinical pharmacokinetics of cabergolinePaolo Del Dotto, Ubaldo Bonuccelli
Neurology|October 13, 2006
New pharmacologic horizons in the treatment of Parkinson diseaseUbaldo Bonuccelli, Paolo Del Dotto
Human Brain Mapping|January 24, 2014
Progression of brain atrophy in the early stages of Parkinson's disease: a longitudinal tensor-based morphometry study in de novo patients without cognitive impairmentCarlo Tessa, Claudio Lucetti, Marco Giannelli, et al.
Expert Review of Neurotherapeutics|June 4, 2015
Apomorphine hydrochloride for the treatment of Parkinson's diseaseElisa Unti, Roberto Ceravolo, Ubaldo Bonuccelli
Expert Opinion on Pharmacotherapy|September 14, 2018
Advances in the pharmacotherapeutic management of dementia with Lewy bodiesGiovanni Palermo, Roberto Ceravolo, Ubaldo Bonuccelli
Journal of Clinical and Experimental Neuropsychology|December 11, 2012
The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-naïve patients with Parkinson's diseaseMichele Poletti, Daniela Frosini, Cristina Pagni, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 12, 2011
Impulsivity and compulsivity in drug-naïve patients with Parkinson's diseaseAngelo Antonini, Chiara Siri, Gabriella Santangelo, et al.
Journal of Clinical Psychopharmacology|July 17, 2013
A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugsMichele Poletti, Chiara Logi, Claudio Lucetti, et al.
Pageof 30